Relevance of induction of human drug-metabolizing enzymes: Pharmacological and toxicological implications

被引:85
作者
Park, BK [1 ]
Kitteringham, NR [1 ]
Pirmohamed, M [1 ]
Tucker, GT [1 ]
机构
[1] UNIV SHEFFIELD, ROYAL HALLAMSHIRE HOSP, DEPT MED & THERAPEUT, SECT PHARMACOL & THERAPEUT, SHEFFIELD S10 2JF, S YORKSHIRE, ENGLAND
基金
英国惠康基金;
关键词
enzyme induction; human; liver; drug metabolism; cytochrome; P450; glucuronidation; toxicity; pharmacodynamics; pharmacokinetics; clearance;
D O I
10.1046/j.1365-2125.1996.03482.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Human drug-metabolizing systems can be induced, or activated, by a large number of exogenous agents including drugs, alcohol, components in the diet and cigarette smoke, as well as by endogenous factors. 2 Such perturbation of enzyme activity undoubtedly contributes to both intra- and inter-individual variation both with respect to the rate and route of metabolism for a particular drug. Induction may, in theory, either attenuate the pharmacological response or exacerbate the toxicity of a particular drug, or both. 3 The clinical impact of enzyme induction will depend upon the number of different enzyme isoforms affected and the magnitude of the inductive response within an individual, and also on the therapeutic indices of the affected substrates. 4 The toxicological implications will be determined either by any change in the route of metabolism, or by a disturbance of the balance between activation and detoxication processes, which may be isozyme selective.
引用
收藏
页码:477 / 491
页数:15
相关论文
共 134 条
  • [1] ROLE OF ETHANOL-INDUCIBLE CYTOCHROME-P450 (P450IIE1) IN CATALYZING THE FREE-RADICAL ACTIVATION OF ALIPHATIC-ALCOHOLS
    ALBANO, E
    TOMASI, A
    PERSSON, JO
    TERELIUS, Y
    GORIAGATTI, L
    INGELMANSUNDBERG, M
    DIANZANI, MU
    [J]. BIOCHEMICAL PHARMACOLOGY, 1991, 41 (12) : 1895 - 1902
  • [2] INTERACTION OF ETHANOL WITH ACETAMINOPHEN METABOLISM IN THE BABOON
    ALTOMARE, E
    LEO, MA
    SATO, C
    VENDEMIALE, G
    LIEBER, CS
    [J]. BIOCHEMICAL PHARMACOLOGY, 1984, 33 (14) : 2207 - 2212
  • [3] LORAZEPAM-VALPROATE INTERACTION - STUDIES IN NORMAL SUBJECTS AND ISOLATED-PERFUSED RAT-LIVER
    ANDERSON, GD
    GIDAL, BE
    KANTOR, ED
    WILENSKY, AJ
    [J]. EPILEPSIA, 1994, 35 (01) : 221 - 225
  • [4] Back David J., 1994, P407
  • [5] 2-HYDROXYLATION OF ETHINYLESTRADIOL IN RELATION TO THE OXIDATION OF SPARTEINE AND ANTIPYRINE
    BACK, DJ
    MAGGS, JL
    PURBA, HS
    NEWBY, S
    PARK, BK
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) : 603 - 607
  • [6] SELECTIVE-INHIBITION OF DRUG OXIDATION AFTER SIMULTANEOUS ADMINISTRATION OF 2 PROBE DRUGS, ANTIPYRINE AND TOLBUTAMIDE
    BACK, DJ
    TJIA, J
    MONIG, H
    OHNHAUS, EE
    PARK, BK
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (02) : 157 - 163
  • [7] BARKER CW, 1994, J BIOL CHEM, V269, P3985
  • [8] ACUTE EFFECTS OF LAMOTRIGINE (BW430C) IN PERSONS WITH EPILEPSY
    BINNIE, CD
    BOAS, WV
    KASTELEIJNNOLSTETRENITE, DGA
    DEKORTE, RA
    MEIJER, JWA
    MEINARDI, H
    MILLER, AA
    OVERWEG, J
    PECK, AW
    VANWIERINGEN, A
    YUEN, WC
    [J]. EPILEPSIA, 1986, 27 (03) : 248 - 254
  • [9] METABOLISM OF 17 ALPHA-ETHYNYLESTRADIOL BY HUMAN LIVER-MICROSOMES INVITRO - AROMATIC HYDROXYLATION AND IRREVERSIBLE PROTEIN-BINDING OF METABOLITES
    BOLT, HM
    KAPPUS, H
    KASBOHRER, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 39 (06) : 1072 - 1080
  • [10] SEQUENCE OF EXONS AND THE FLANKING REGIONS OF HUMAN BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE GENE-COMPLEX AND IDENTIFICATION OF A GENETIC MUTATION IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME, TYPE-I
    BOSMA, PJ
    CHOWDHURY, NR
    GOLDHOORN, BG
    HOFKER, MH
    ELFERINK, RPJO
    JANSEN, PLM
    CHOWDHURY, JR
    [J]. HEPATOLOGY, 1992, 15 (05) : 941 - 947